MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0011545
Sirak Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.97 Cr
▼ 46% YoY
Net profit · FY 2024
₹44.47 Lakh
Net margin 15%
EBITDA · FY 2024
₹2.23 Cr
EBITDA margin 75.1%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.34 Cr
Issued & subscribed
Open charges
₹11.48 Cr
Satisfied ₹4.95 Cr
Company age
18 yrs
Est. 2008
Directors on board
4
As per MCA filings
About Sirak Pharmaceuticals Private Limited
Data last updated:
Sirak Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 08 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC057045. Its GSTIN is 36AALCS7150B1ZF (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.34 Cr. It is led by directors including Swaroopkumar Venkata Satya Vakkalanka and Sita Samyukta Vakkalanka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.97 Cr, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹44.47 Lakh (net margin 15%) and EBITDA of ₹2.23 Cr (EBITDA margin 75.1%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹11.48 Cr and satisfied charges of ₹4.95 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 1 case is pending.
Sirak Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011545). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sirakpharma.com.
Company details
CIN U24232TG2008PTC057045
Registration Number 057045
Incorporation Date 08 January 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0011545
CIN history
Sirak Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2008PTC057045. The current CIN is U24232TG2008PTC057045, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC057045 | Current |
| U24232AP2008PTC057045 | Previous |
Key People
Swaroopkumar Venkata Satya Vakkalanka Director Sita Samyukta Vakkalanka Director Satya Kameswari Vakkalanka Director Recognitions & Rankings of Sirak Pharmaceuticals
Contact details
Sirak Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is sirakpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 01B1 12A01B1 12A (13th) Floor Manjeera Trinity Corporation Jntu Rd K, Ukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Sirak Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sirak Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Sirak Pharmaceuticals Private Limited
FY 2025 filings availableSirak Pharmaceuticals Private Limited reported revenue of ₹2.97 Cr (down 46% YoY) for FY 2024.
Revenue · FY 2024
₹2.97 Cr ▼ 46%
Net profit · FY 2024
₹44.47 Lakh margin 15%
EBITDA · FY 2024
₹2.23 Cr margin 75.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 31%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 24%
5 years · compounded
▼ 15%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 46% fall in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 75.1% | ||||
| Net Profit Margin | 15% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sirak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sirak Pharmaceuticals Private Limited
Sirak Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swaroopkumar Venkata Satya Vakkalanka Also directs: Zaian Remedies LLP | Director | 08 Jan 2008 | 18 Years 9 Months | Current |
| Sita Samyukta Vakkalanka | Director | 01 Apr 2025 | 1 Years 7 Months | Current |
| Satya Kameswari Vakkalanka | Director | 08 Jan 2008 | 18 Years 9 Months | Current |
| Thappali Ramaswamy Sethuraman Satheesh Manikandan Also directs: Fenix Research Labs Private Limited | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Sirak Pharmaceuticals Private Limited is audited by A R Murthy & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A R Murthy & Co | FY 2022 | 002203S |
Shareholding
The shareholding of Sirak Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sirak Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.48 Cr
Satisfied charges
₹4.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Feb 2024 | 100865612 | Hdfc Bank Limited | ₹4.03 Cr | Open | |
| 29 Oct 2022 | 100628562 | Yes Bank Limited | ₹7.45 Cr | Open | |
| 29 Feb 2020 | 100332244 | Yes Bank Limited | ₹1 Cr | Satisfied | |
| 01 Nov 2016 | 100098221 | Hdfc Bank Limited | ₹2.45 Cr | Satisfied | |
| 17 Apr 2015 | 10575969 | Hdfc Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Sirak Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Sirak Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Sirak Pharmaceuticals. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
| District courts | 1 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against Tamballa Raghu Kumar, Proprietor of Ms.Gobal Enterprises | Pending |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Sirak Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sirak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sirak Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCS7150B1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sirak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sirak Pharmaceuticals Private Limited has 6 board changes on record since 2008: 4 appointments and 2 cessations. The latest: Sita Samyukta Vakkalanka ceased to be Additional Director on 29 Sep 2025.
AGM
Sirak Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sita Samyukta Vakkalanka ceased to be Additional Director.
Appointed
Sita Samyukta Vakkalanka was appointed as Director.
Filing
Sirak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.03 Cr with Charge ID 100865612 was registered on 06 Feb 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 7.45 Cr with Charge ID 100628562 was registered on 29 Oct 2022.
Ceased
Thappali Ramaswamy Sethuraman Satheesh Manikandan ceased to be Additional Director.
Charges
A charge registered on 01 Nov 2016 via Charge ID 100098221 with Hdfc Bank Limited was fully satisfied on 23 May 2022.
Charges
A charge registered on 17 Apr 2015 via Charge ID 10575969 with Hdfc Bank Limited was fully satisfied on 10 May 2022.
Charges
A charge registered on 29 Feb 2020 via Charge ID 100332244 with Yes Bank Limited was fully satisfied on 28 Apr 2022.
Appointed
Thappali Ramaswamy Sethuraman Satheesh Manikandan was appointed as Director.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100332244 was registered on 29 Feb 2020.
5 earlier events are in the company report.
Frequently asked questions
Sirak Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 08 January 2008 (18+ years old) and is registered under CIN U24232TG2008PTC057045.
Sirak Pharmaceuticals has 4 current directors:
- Swaroopkumar Venkata Satya Vakkalanka - Director
- Sita Samyukta Vakkalanka - Director
- Satya Kameswari Vakkalanka - Director
- Thappali Ramaswamy Sethuraman Satheesh Manikandan - Director
The latest financial statements of Sirak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sirak Pharmaceuticals is 36AALCS7150B1ZF, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sirak Pharmaceuticals is U24232TG2008PTC057045. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sirak Pharmaceuticals has 3 court cases on record: 3 filed by the company. 1 is pending. Most are in the nclt.
Sirak Pharmaceuticals was incorporated on 08 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sita Samyukta Vakkalanka ceased to be Additional Director on 29 Sep 2025. Sita Samyukta Vakkalanka was appointed as Director on 01 Apr 2025. Thappali Ramaswamy Sethuraman Satheesh Manikandan ceased to be Additional Director on 30 Sep 2022. Sirak Pharmaceuticals has 6 board changes on record in total.
Yes, Sirak Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0011545).
Sirak Pharmaceuticals can be reached through the website sirakpharma.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages